Скачать или смотреть NF Knowledge Series: New Pathways for Plexiform Neurofibromas

This webinar is part of the Children's Tumor Foundation NF Knowledge Series and was recorded live on August 14, 2025. Hosted by Dr. Stephanie Bouley, the webinar explores how tumor cells differ from healthy ones in NF1—and where we can target them next.

Be sure to subscribe (and click the bell!) to receive alerts when we post a new video: https://www.youtube.com/user/ctforg?s...

About CTF:
The Children’s Tumor Foundation (CTF) is the drug discovery engine for NF. Everything we do is to bring treatments to patients as we work toward a cure. By connecting patients, doctors, scientists, and pharma, we drive treatments, advance care, and deliver results for millions affected by neurofibromatosis or schwannomatosis, collectively referred to as NF. Our patient-first collaborative approach accelerates drug development and brings life-changing therapies to patients faster, driven by our mission to end NF.

What is NF?
NF refers to a group of genetic conditions that cause tumors to grow on nerves throughout the body. NF affects 1 in 2,000 births and may lead to blindness, deafness, bone abnormalities, disfigurement, learning disabilities, disabling pain, or cancer. NF affects all races, ethnic groups, and genders equally. The types of NF include neurofibromatosis type 1 (NF1) and all types of schwannomatosis (SWN), including NF2-related schwannomatosis (NF2-SWN), formerly called neurofibromatosis type 2 (NF2).

Visit our website at https://www.ctf.org/
Donate today at https://www.ctf.org/ways-to-give/

Follow us on our social media platforms:
Facebook -   / childrenstumor  
Instagram -   / childrenstumor  
X -   / childrenstumor  
LinkedIn -   / children's-tumor-foundation  
TikTok -   / childrenstumor  

#endnf #nf1 #nf2 #nf2swn #swn #childrenstumor #neurofibromatosis #schwannomatosis #nervetumor #tumor